Showing results (231-240 of 443) with videos related to

Sort By:
Pageof 45
Blood|June 8, 2013
CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemiaMargaret L Green, Wendy M Leisenring, Hu Xie, et al.
Transplantation|May 30, 2006
RDP58 does not prevent graft-versus-host disease after dog leukocyte antigen-nonidentical canine hematopoietic cell transplantationChristian S Kuhr, Marilena Lupu, Marie-Térèse Little, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 12, 2016
Minimal Identifiable Disease and the Role of Conditioning Intensity in Hematopoietic Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Evolving from Myelodysplastic SyndromeMoreno Festuccia, H Joachim Deeg, Theodore A Gooley, et al.
Blood|January 17, 2013
Failure-free survival after second-line systemic treatment of chronic graft-versus-host diseaseYoshihiro Inamoto, Barry E Storer, Stephanie J Lee, et al.
Blood|August 16, 2003
Allogeneic hematopoietic stem cell transplantation for myelofibrosisH Joachim Deeg, Theodore A Gooley, Mary E D Flowers, et al.
Blood|June 28, 2007
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioningChristoph Kahl, Barry E Storer, Brenda M Sandmaier, et al.
Transplantation and Cellular Therapy|October 2, 2022
The ASTCT-NMDP ACCESS Initiative: A Collaboration to Address and Sustain Equal Outcomes for All across the Hematopoietic Cell Transplantation and Cellular Therapy EcosystemJeffery J Auletta, Brenda M Sandmaier, Erica Jensen, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 21, 2013
High prevalence of potential drug interactions affecting mycophenolic acid pharmacokinetics in nonmyeloablative hematopoietic stem cell transplant recipientsAlenka Jaklič, Carol J Collins, Aleš Mrhar, et al.
Leukemia|December 12, 2024
Relationship between donor source, pre-transplant measurable residual disease, and outcome after allografting for adults with acute myeloid leukemiaCorentin Orvain, Filippo Milano, Eduardo Rodríguez-Arbolí, et al.
Transplantation Direct|July 19, 2016
Minor Antigen Vaccine-Sensitized DLI: In Vitro Responses Do Not Predict In Vivo EffectsSteven Lawrence Rosinski, Brad Stone, Scott S Graves, et al.
Pageof 45